Neoadjuvant Chemotherapy for Advanced Epithelial Ovarian Cancer. Who Really Benefits?

Australian and New Zealand Journal of Obstetrics and Gynaecology - United States
doi 10.1111/ajo.12737
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Evaluating the Benefits of Neoadjuvant Chemotherapy for Advanced Epithelial Ovarian Cancer: A Retrospective Study

Journal of Ovarian Research
GynecologyOncologyObstetrics
2019English

Neoadjuvant Chemotherapy for Patients With Advanced Epithelial Ovarian Cancer: A Meta-Analysis

Scientific Reports
Multidisciplinary
2016English

Neoadjuvant Chemotherapy in Advanced Ovarian Cancer: Latest Results and Place in Therapy

Therapeutic Advances in Medical Oncology
Oncology
2014English

Apatinib Treatment Combined With Chemotherapy for Advanced Epithelial Ovarian Cancer: A Case Report

OncoTargets and Therapy
OncologyPharmacology
2017English

Neoadjuvant Chemotherapy of Resectable Advanced Gastric Cancer

Nihon Gekakei Rengo Gakkaishi (Journal of Japanese College of Surgeons)
2012English

Overall Survival Following Neoadjuvant Chemotherapy vs Primary Cytoreductive Surgery in Women With Epithelial Ovarian Cancer

JAMA Oncology
Cancer ResearchOncology
2017English

Interval Debulking Surgery for Advanced Epithelial Ovarian Cancer

Cochrane Database of Systematic Reviews
2016English

Interval Debulking Surgery for Advanced Epithelial Ovarian Cancer

2010English

Effect of Adoption of Neoadjuvant Chemotherapy for Advanced Ovarian Cancer on All Cause Mortality: Quasi-Experimental Study

British Medical Journal
Medicine
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy